Many Bright Ideas Technologies Inc.

Equities

MBI.H

CA5650851077

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 10:20:17 2024-06-10 am EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	+150.00%

May. 24	Many Bright Ideas Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Med Biogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 14, 2021 at 01:00 pm EDT

Med BioGene Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced net loss was USD 21,175 compared to USD 15,519 a year ago.

Latest news about Many Bright Ideas Technologies Inc.

Many Bright Ideas Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 24	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 24	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-21	CI
Many Bright Ideas Technologies Inc. Auditor Raises 'Going Concern' Doubt	23-04-20	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-25	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Med BioGene Inc. will Change its Name to Many Bright Ideas Technologies Inc	22-06-15	CI
Med BioGene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-26	CI
Med BioGene Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI
Med BioGene Inc. Auditor Raises 'Going Concern' Doubt	22-04-21	CI
Hillhouse, others set to invest $630 million in China's Giant Biogene -sources	21-12-07	RE
Med BioGene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-26	CI
Med Biogene Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-27	CI
Med Biogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Med Biogene Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-25	CI
Med BioGene Inc. Auditor Raises 'Going Concern' Doubt	21-03-24	CI
Med BioGene Inc. announced that it has received CAD 0.1 million in funding from Weir-Jones Engineering Consultants Ltd.	21-02-03	CI
Med BioGene Inc. announced that it expects to receive CAD 0.1 million in funding from Weir-Jones Engineering Consultants Ltd.	21-01-06	CI
Med Biogene Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
Med Biogene Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-31	CI
Med Biogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-29	CI
Med Biogene Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-29	CI

Chart Many Bright Ideas Technologies Inc.

Duration

Period

Chart Many Bright Ideas Technologies Inc.

More charts

Company Profile

Many Bright Ideas Technologies Inc. is a Canada-based company. The Company is focused on commercializing alternative non-medical technologies. It has not generated any revenue.

Sector

Biotechnology & Medical Research

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
MANY BRIGHT IDEAS TECHNOLOGIES INC.	+150.00%	314K
EXACT SCIENCES CORPORATION	-42.02%	7.91B
GUARDANT HEALTH, INC.	+11.13%	3.68B
IOVANCE BIOTHERAPEUTICS, INC.	-0.92%	2.25B
BGI GENOMICS CO., LTD.	-21.69%	1.97B
VERACYTE, INC.	-24.10%	1.6B
CAREDX, INC	+24.33%	777M
SEEGENE, INC.	-10.48%	687M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-28.78%	514M
CURIOX BIOSYSTEMS CO., LTD	-1.29%	290M

Bio Diagnostics & Testing